BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102 | -100.0% | 7,365 | -50.0% | 0.07% | -95.4% |
| Q3 2022 | $2,227,000 | +1.9% | 14,730 | -1.8% | 1.57% | -1.4% |
| Q2 2022 | $2,186,000 | +31.7% | 15,000 | +7.1% | 1.59% | +33.1% |
| Q1 2022 | $1,660,000 | +0.4% | 14,000 | +16.7% | 1.20% | +12.0% |
| Q4 2021 | $1,654,000 | +19.1% | 12,000 | +20.0% | 1.07% | +12.9% |
| Q3 2021 | $1,389,000 | +43.0% | 10,000 | 0.0% | 0.94% | +62.7% |
| Q2 2021 | $971,000 | +42.0% | 10,000 | 0.0% | 0.58% | +43.1% |
| Q1 2021 | $684,000 | -20.2% | 10,000 | 0.0% | 0.41% | -17.8% |
| Q4 2020 | $857,000 | -34.1% | 10,000 | -50.0% | 0.49% | +13.8% |
| Q3 2020 | $1,300,000 | +77.8% | 20,000 | +100.0% | 0.43% | -1.8% |
| Q2 2020 | $731,000 | +115.0% | 10,000 | 0.0% | 0.44% | +46.4% |
| Q1 2020 | $340,000 | -37.5% | 10,000 | 0.0% | 0.30% | -23.5% |
| Q4 2019 | $544,000 | – | 10,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |